BRAF and melanoma: Moreover, mTORC activation was also reported to be also able to block the V600EBRAF-induced growth arrest and was required for evasion from oncogene-induced senescence in human melanomas harboring oncogenic BRAF [53], thus highlighting a role for PI3K-AKT-mTOR pathway in the negative control of the senescence-like phenotype.